Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-002859-41Phase 3Completed
Phase 3, randomised, single-blind trial of honey bee hymenoptera venom in Honey bee venom allergy (HBVA) (2 arms), sponsored by HAL Allergy Group. Primary endpoint: Systemic reactions to re-sting. Started Aug 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-002859-41.